Резонатив

Резонатив is a Human Anti-D Immunoglobulin solution used to prevent hemolytic disease of the newborn. This product is derived from human plasma and is administered via intramuscular injection. Suitable for Rh-negative individuals at risk of Rh sensitization.

Резонатив is primarily used to prevent Rh sensitization in Rh-negative individuals, particularly during pregnancy or after exposure to Rh-positive blood. It works by providing passive antibodies that neutralize Rh-positive red blood cells before the immune system can respond. This helps protect future pregnancies from hemolytic disease of the newborn. It may also be used in other medical scenarios where Rh incompatibility poses a risk.

Резонатив provides temporary protection by supplying pre-formed antibodies that target Rh-positive cells. This action helps prevent the immune system from developing long-term sensitization to Rh-positive blood. The effects are temporary and do not alter the individual's own immune response permanently. Most users tolerate it well with minimal immediate effects.

Store Резонатив refrigerated between 2°C and 8°C (36°F and 46°F) and protect from light. Do not freeze. Inspect the solution for particles or discoloration before use; discard if either is present. Follow healthcare provider instructions for proper handling and disposal. Inform your doctor of any allergies or previous reactions to immunoglobulin products.

Concurrent use of live vaccines may reduce vaccine effectiveness; consult a healthcare provider for timing recommendations. Immunoglobulin products like Резонатив may interact with certain medications that affect the immune system, such as immunosuppressants. Alcohol and tobacco use may influence overall treatment outcomes but do not directly interact with the product itself.